[Differential diagnosis between osteoporosis and asymptomatic primary hyperparathyroidism]

Area of Science:

• Endocrinology
• Genetics
• Metabolic Bone Disease

Context:

• Asymptomatic primary hyperparathyroidism (aPHPT) cases are rising, posing diagnostic challenges.
• While diagnosis is feasible with regular biochemical monitoring, surgical criteria remain unclear due to unknown long-term outcomes.
• Bone mineral density (BMD) is a key concern in aPHPT management.

Purpose:

• To explore potential new criteria for surgical intervention in aPHPT patients.
• To investigate the role of vitamin D receptor (VDR) gene polymorphism in aPHPT management.
• To address the uncertainty surrounding the natural progression of aPHPT, particularly concerning BMD.

Summary:

• Diagnosis of aPHPT is achievable through monitoring serum calcium, phosphorus, and intact parathyroid hormone (PTH).
• Elevated alkaline phosphatase may occur in some postmenopausal women with aPHPT.
• The genetic analysis of VDR gene polymorphism is proposed as a future criterion for surgical decision-making in aPHPT.

Impact:

• This research could lead to more informed surgical decisions for aPHPT.
• Identifying genetic markers may personalize treatment strategies for hyperparathyroidism.
• Improved understanding of aPHPT progression can enhance patient care and outcomes, particularly for bone health.